$XBP
XBP Europe Holdings Inc Stock $xbp

$xbp Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023024115 Filed on March 29, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit		$43.71M
YoY Change
Gross Profit Margin
Selling, General & Admin	$768.7K	$2.884M	$2.736M
YoY Change	-22.44%	5.43%
% of Gross Profit		6.6%
Research & Development		$1.100M
YoY Change
% of Gross Profit		2.52%
Depreciation & Amortization		$4.390M
YoY Change
% of Gross Profit		10.04%
Operating Expenses	$768.7K	$2.884M	$2.736M
YoY Change	-22.44%	5.43%
Operating Profit		-$2.884M	-$2.736M
YoY Change		5.43%
Interest Expense	-$462.8K	$742.8K	-$1.989M
YoY Change	-89092.31%	-137.35%
% of Operating Profit
Other Income/Expense, Net	$30.99K	$100.0K	$3.017M
YoY Change	-98.2%	-96.69%
Pretax Income	-$1.201M	$2.505M	-$1.708M
YoY Change	-263.85%	-246.65%
Income Tax	-$27.59K	$111.0K
% Of Pretax Income		4.43%
Net Earnings	-$1.173M	$2.394M	-$1.708M
YoY Change	-260.08%	-240.15%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.36
Diluted Earnings Per Share	-$0.12	$0.25	-$64.54K
COMMON SHARES
Basic Shares Outstanding		21.80M
Diluted Shares Outstanding		21.80M

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.15K	$41.15K	$25.00K
YoY Change	64.6%	64.6%	-16.67%
Cash & Equivalents	$41.15K
Short-Term Investments
Other Short-Term Assets	$210.2K	$210.2K	$195.5K
YoY Change	7.56%	7.56%
Inventory	$4.526M
Prepaid Expenses	$210.2K
Receivables	$35.98M
Other Receivables
Total Short-Term Assets	$251.4K	$251.4K	$220.5K
YoY Change	14.03%	14.03%	634.87%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$22.06M
YoY Change	-7.89%
Intangibles	$1.529M
YoY Change
Long-Term Investments	$31.45M	$31.45M	$250.0M
YoY Change	-87.42%	-87.42%
Other Assets		$0.00	$570.8K
YoY Change		-100.0%
Total Long-Term Assets	$31.45M	$31.45M	$250.6M
YoY Change	-87.45%	-87.45%
TOTAL ASSETS
Total Short-Term Assets	$251.4K	$251.4K	$220.5K
Total Long-Term Assets	$31.45M	$31.45M	$250.6M
Total Assets	$31.70M	$31.70M	$250.8M
YoY Change	-87.36%	-87.36%	835929.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$16.86M
YoY Change
Accrued Expenses	$1.190M	$1.260M	$1.349M
YoY Change	-11.82%	-6.63%
Deferred Revenue	$5.660M
YoY Change	-1.74%
Short-Term Debt	$8.200M	$8.200M	$734.4K
YoY Change	1016.53%	1016.53%
Long-Term Debt Due	$4.970M
YoY Change
Total Short-Term Liabilities	$9.460M	$9.460M	$2.854M
YoY Change	231.41%	231.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.683M	$2.683M	$7.307M
YoY Change	-63.28%	-63.28%
Total Long-Term Liabilities	$2.683M	$2.683M	$7.307M
YoY Change	-63.28%	-63.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.460M	$9.460M	$2.854M
Total Long-Term Liabilities	$2.683M	$2.683M	$7.307M
Total Liabilities	$12.14M	$12.14M	$10.16M
YoY Change	19.5%	19.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.31M
YoY Change	29.6%
Common Stock	$54.00
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$11.62M	$19.55M	$240.6M
YoY Change
Total Liabilities & Shareholders Equity	$31.70M	$31.70M	$250.8M
YoY Change	-87.36%	-87.36%	835929.93%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$1.173M	$2.394M	-$1.708M
YoY Change	-260.08%	-240.15%
Depreciation, Depletion And Amortization		$4.390M
YoY Change
Cash From Operating Activities	$0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures		$6.366M
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$28.16K	$219.8M	-$250.0M
YoY Change		-187.92%
Cash From Investing Activities	$28.16K	$219.8M	-$250.0M
YoY Change		-187.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-252.2K	-$219.8M	250.0M
YoY Change		-187.92%	833233.33%
NET CHANGE
Cash From Operating Activities	0.000
Cash From Investing Activities	28.16K	$219.8M	-250.0M
Cash From Financing Activities	-252.2K	-$219.8M	250.0M
Net Change In Cash	-224.0K	$16.15K	$0.00
YoY Change			-100.0%
FREE CASH FLOW
Cash From Operating Activities	$0.00
Capital Expenditures		$6.366M
Free Cash Flow		-$6.366M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity File Number EntityFileNumber	001-40206
CY2022	dei	Entity Registrant Name EntityRegistrantName	CF ACQUISITION CORP. VIII
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2002883
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	110 East 59th Street
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2022	dei	City Area Code CityAreaCode	(212)
CY2022	dei	Local Phone Number LocalPhoneNumber	938-5000
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	CFFE
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q2	dei	Entity Public Float EntityPublicFloat	223633938	usd
CY2022	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2022	dei	Auditor Location AuditorLocation	New York
CY2022	dei	Auditor Firm AuditorFirmId	100
CY2022Q4	us-gaap	Cash Cash	41154	usd
CY2021Q4	us-gaap	Cash Cash	25000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	210241	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	195463	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	251395	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	220463	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	31445874	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	250017673	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	570844	usd
CY2022Q4	us-gaap	Assets Assets	31697269	usd
CY2021Q4	us-gaap	Assets Assets	250808980	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1189676	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1349132	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	570844	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	8200162	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	734425	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	70065	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	200000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9459903	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2854401	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	178780	usd
CY2021Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5300188	usd
CY2022Q4	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	2504214	usd
CY2021Q4	cffe	Forward Purchase Securities Liability ForwardPurchaseSecuritiesLiability	2006525	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12142897	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10161114	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	31169832	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	250000000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	54	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	54	usd
CY2022Q4	cffe	Common Stock Value One CommonStockValueOne	625	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	694592	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	146555	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12310731	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9499368	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11615460	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9352134	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31697269	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	250808980	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2601894	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2440245	usd
CY2022	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	120000	usd
CY2021	us-gaap	Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty	95161	usd
CY2022	us-gaap	Taxes Other TaxesOther	162534	usd
CY2021	us-gaap	Taxes Other TaxesOther	200500	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2884428	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2735906	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	1240443	usd
CY2021	us-gaap	Interest Income Other InterestIncomeOther	17673	usd
CY2022	cffe	Interest Expense Mandatorily Redeemable Securities InterestExpenseMandatorilyRedeemableSecurities	1054486	usd
CY2022	us-gaap	Other Income OtherIncome	579294	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5121408	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3016913	usd
CY2022	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	497689	usd
CY2021	cffe	Change In Fair Value Of Forward Purchase Securities Liability ChangeInFairValueOfForwardPurchaseSecuritiesLiability	2006525	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	2504542	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1707845	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111023	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2393519	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1707845	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	23579	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	5224149	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	0.0001	usd
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	13038572	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	146555	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1707845	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9352134	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	49411	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	694592	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	5400848	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2393519	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-11615460	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2393519	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1707845	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	49411	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	146555	usd
CY2022	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	2040571	usd
CY2021	cffe	General And Administrative Expenses Paid By Related Party GeneralAndAdministrativeExpensesPaidByRelatedParty	178877	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1240443	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	17673	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1054486	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5121408	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3016913	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	497689	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	2006526	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-159456	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1347711	usd
CY2022	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	-129935	usd
CY2021	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	200000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-615566	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-291918	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	570844	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	5400847	usd
CY2021	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	250000000	usd
CY2022	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes	292469	usd
CY2022	cffe	Proceeds From Trust Account To Redeem Public Shares ProceedsFromTrustAccountToRedeemPublicShares	224920621	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	224056750	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	225000000	usd
CY2022	cffe	Payment To Acquire Available For Sale Securities PaymentToAcquireAvailableForSaleSecurities	224056750	usd
CY2022	cffe	Maturity Of Availableforsale Debt Securities Held In Trust Account MaturityOfAvailableforsaleDebtSecuritiesHeldInTrustAccount	225000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	219812243	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-250000000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	7795448	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	734425	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	250000000	usd
CY2022	cffe	Redemption Paymentfor Public Shares RedemptionPaymentforPublicShares	224920621	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	5400000	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4897322	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2670916	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1237103	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-219796089	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	250000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	16154	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41154	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25000	usd
CY2022	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty	59500	usd
CY2021	cffe	Prepaid Expenses Paid With Payables To Related Party PrepaidExpensesPaidWithPayablesToRelatedParty	1058225	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	4900000	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	4500000	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	400000	usd
CY2022	cffe	Redeem Public Share Percentage RedeemPublicSharePercentage	1	pure
CY2022Q3	cffe	Extensions Loan ExtensionsLoan	976832	usd
CY2022Q3	cffe	Public Share Per Share PublicSharePerShare	0.33
CY2022Q4	us-gaap	Cash Cash	41200	usd
CY2021Q4	us-gaap	Cash Cash	25000	usd
CY2022Q4	cffe	Working Capital WorkingCapital	9209000	usd
CY2021Q4	cffe	Working Capital WorkingCapital	2634000	usd
CY2022	cffe	Liquidity And Capital Resource Description LiquidityAndCapitalResourceDescription	The Company’s liquidity needs through December 31, 2022 have been satisfied through a contribution of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, a loan of approximately $79,000 from the Sponsor pursuant to a promissory note (the “Pre-IPO Note”) (see Note 4), the proceeds from the sale of the Private Placement Units not held in the Trust Account, the Sponsor Loan (as defined below), the First Working Capital Loan (as defined below) and the Second Working Capital Loan (as defined below).
CY2022Q4	cffe	Maximum Sponsor Loan MaximumSponsorLoan	1750000	usd
CY2022Q2	cffe	Working Capital Loan WorkingCapitalLoan	1000000	usd
CY2022Q4	cffe	Working Capital Loan WorkingCapitalLoan	750000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	100000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liability, FPS liability, and sponsor loans liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Deposit Insurance Corporation maximum coverage limit of $250,000, and cash equivalents held in the Trust Account. For the years ended December 31, 2022 and 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022	cffe	Other Expense OtherExpense	689606	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	111000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.044	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0	pure
CY2021Q1	cffe	Issued And Outstanding Shares Percentage IssuedAndOutstandingSharesPercentage	0.20	pure
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	147000	usd
CY2021Q1	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On March 11, 2021, the Company effected a 1.1-for-1 stock split.
CY2021Q1	cffe	Initial Shareholders Holding Percentage InitialShareholdersHoldingPercentage	0.20	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	733400	shares
CY2022Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	1750000	usd
CY2022	us-gaap	Other General Expense OtherGeneralExpense	10000	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	120000	usd
CY2021	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	95000	usd
CY2022Q4	cffe	Related Party Loan RelatedPartyLoan	750000	usd
CY2022Q3	cffe	Extensions Loan ExtensionsLoan	976832	usd
CY2022Q3	cffe	Public Share Per Share PublicSharePerShare	0.33
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	540000	shares
CY2022Q4	cffe	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	2960098	shares
CY2021Q4	cffe	Common Stock Subject To Possible Redemption CommonStockSubjectToPossibleRedemption	25000000	shares
CY2022	cffe	Issued And Outstanding Ordinary Shares Percentage IssuedAndOutstandingOrdinarySharesPercentage	0.20	pure
CY2021Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On March 11, 2021, the Company effected a 1.1-for-1 stock split.
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	cffe	Public Warrants Term PublicWarrantsTerm	P5Y
CY2022	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	●in whole and not in part; ● at a price of $0.01 per warrant; ● at any time during the exercise period; ● upon a minimum of 30 days’ prior written notice of redemption; ● if, and only if, the last reported sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending on the third business day prior to the date on which the Company sends the notice of redemption to the warrant holders; and ● if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants.
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	111000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	111023	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-411243	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-571138	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	411243	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	571138	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	111023	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	935979	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	501658	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	41153	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	30777	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	5250	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	38703	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	982382	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	571138	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	982382	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	571138	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	-0.429	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies State And Local EffectiveIncomeTaxRateReconciliationTaxContingenciesStateAndLocal	0.371	pure
CY2022	cffe	Change In Fair Value Of Fps Liability ChangeInFairValueOfFPSLiability	0.042	pure
CY2021	cffe	Change In Fair Value Of Fps Liability ChangeInFairValueOfFPSLiability	-0.247	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.163	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.334	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.044	pure
CY2022Q4	cffe	Fps Commitment FPSCommitment	10000000	usd
CY2022Q4	us-gaap	Commitments Fair Value Disclosure CommitmentsFairValueDisclosure	10000000	usd
CY2022	cffe	Business Combination Percentage BusinessCombinationPercentage	0.80	pure
CY2022	us-gaap	Sponsor Fees SponsorFees	7534106	usd
CY2023Q1	cffe	Extension Loan ExtensionLoan	344781	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10.69
CY2023Q1	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	16290945	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties		usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities		usd
CY2021	cffe	Proceeds From Trust Account To Pay Franchise Taxes ProceedsFromTrustAccountToPayFranchiseTaxes		usd
CY2021	cffe	Proceeds From Trust Account To Redeem Public Shares ProceedsFromTrustAccountToRedeemPublicShares		usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments		usd
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2021	cffe	Payment To Acquire Available For Sale Securities PaymentToAcquireAvailableForSaleSecurities		usd
CY2021	cffe	Maturity Of Availableforsale Debt Securities Held In Trust Account MaturityOfAvailableforsaleDebtSecuritiesHeldInTrustAccount		usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2021	cffe	Redemption Paymentfor Public Shares RedemptionPaymentforPublicShares		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities		usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001839530

Files In Submission

Name	View Source	Status
0001213900-23-024115-index-headers.html	Edgar Link	pending
0001213900-23-024115-index.html	Edgar Link	pending
0001213900-23-024115.txt	Edgar Link	pending
0001213900-23-024115-xbrl.zip	Edgar Link	pending
cffe-20221231.xsd	Edgar Link	pending
f10k2022ex31-1_cfacquis8.htm	Edgar Link	pending
f10k2022ex31-2_cfacquis8.htm	Edgar Link	pending
f10k2022ex32-1_cfacquis8.htm	Edgar Link	pending
f10k2022ex32-2_cfacquis8.htm	Edgar Link	pending
f10k2022ex4-5_cfacquis8.htm	Edgar Link	pending
f10k2022_cfacq8.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cffe-20221231_cal.xml	Edgar Link	unprocessable
f10k2022_cfacq8_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cffe-20221231_lab.xml	Edgar Link	unprocessable
cffe-20221231_pre.xml	Edgar Link	unprocessable
cffe-20221231_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XBP
XBP Europe Holdings Inc Stock $xbp

2022 Q4 Form 10-K Financial Statement

#000121390023024115 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP XBP Europe Holdings Inc Stock $xbp

2022 Q4 Form 10-K Financial Statement

#000121390023024115 Filed on March 29, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XBP
XBP Europe Holdings Inc Stock $xbp